Abstract:BACKGROUND: Vascular endothelial growth factor (VEGF) can specifically promote the division and proliferation of endothelial cells and the revascularization, finally induce angiopoiesis. Recently, VEGF-based gene therapy has been gradually used in clinical trials, but some limits on usually used vectors deserve further studies, including the low transfection efficiency of plasmid vector, the immunogenicity of adnovirus vector to host cells and the potential risk of infection. OBJECTIVE: To construct the non-pathogenic recombinant adeno-associated vires (AAV) co-expressing human vascular endethelial growth factor 165 (hVEGF165) and green fluorescent protein (GFP) label and measure the virus titer and assess its biological activity.DESIGN, TIME AND SETTING: The open experiment was performed at the Vitrus Laboratory of Shanxi Provincial Center for Disease Control and Prevention from March to September 2007.MATERIALS: AAV-293 virus packaging cell line, AAV HT-1080 cells were purchased from Swatagene, USA. E.coli DH5α was a stocked strain from Shanxi Provincial Center for Disease Control and Prevention. AAV Helper Free System (pAAV-IRES-GFP vector containing GFP label) was purchased from Stratagene, USA. Plasmid pUC18-hVEGF165 was constructed previously by Dr.Shi from Department of Orthopaedics of Second Affiliated Hospital of Xi'an Jiaotong University.METHODS: The hVEGF165 gone from plasmid pUC18-hVEGF165 was amplified and inserted into plasmid pAAV-IRES-hrGFP. Then recombinant plasmid pAAV-hVEGF165-IRES-hrGFP, pAAV-RC and pAAV-Helper were co-transfected into AAV-293 cells to complete rAAV-hVEGF165-IRES-hrGFP packaging through homologous recombination. The efficiency of A.AV packaging was monitored under a fluorescent microscope, and the recombinant viral particles were harvested from infected AAV-293 cells and further concentrated and purified. The recombinant virus infected the AAV-HT1080 cells, the virus titer was measured by fluorescence counting, and the recombinant AAV-hVEGF165-IRES-hrGFP was verified by the amplification of the exogenous gene of hVEGF165 from virus genome.MAIN OUTCOME MEASURES: Virus packaging efficiency was monitored under the fluorescence microscope. Virus filer was measured by fluorescent counting. The packaging of recombinant virus was determined by the amplification of the exogenous hVEGF165 gene.RESULTS: The amplified products were verified as hVEGF165 gene by DNA sequencing, and the recombinant pAAV-hVEGF165-IRES-hrGFP was confirmed by double digestion. The system provided a high packaging ratio of over 95% and the purified recombinant virus had a high titer of 5.5×1011 vp/mL. The recombinant virus was confirmed by exogenous human VEGF165 gene from virus genome.CONCLUSION: The non-pathogenic rAAV-hVEGF165-GFP simultaneously carrying hVEGF165 and GFP 1abel is successfully constructed, with a high titer and satisfying biological activity.

Preparation of the Antiangiogenic Peptide Alphastatin Recombinant Adeno-Associated Virus

Construction of Recombinant Lentivirus Vector for Tumor Vasoinhibitory Peptide Alphastatin Gene Delivery

Construction, Packaging and Titration of Recombinant Adeno-Associated Virus Vectors Contaning Antitumor Genes

The construction and production of NT4-GFP-Ant recombinant adeno-associated virus

Construction of Recombined Adeno-Associated Virus Vector Expressing DⅡ4 Short RNA Interference and Preparation of High-Titer Virus

Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection

Construction of a gengeral adeno-associated virus vector and GFP expression in rat NIH3T3 transduced by the rAAV vector

Establishment of A Recombinant Adeno-Associated Virus Expressing Hvegf(165)

Cloning and sequencing of antianiogenic peptide alphastatin gene

[Serial Recombinant Expression and Anti-Tumor Activity in Vitro of Antibiotic Peptide Alloferon-1].

Construction and Identification of Recombinant Adeno- Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor and Green Fluorescent Protein

Study on the Construction of Recombinant AAV Vector Mediated Tumstatin Gene and Its Activity

Preparation of Recombinant Adeno-associated Virus Carrying Heme Oxygenase-1 Gene

A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors.

Cloning of Stellate Cell Activation-associated Protein(STAP)Gene and Construction of Its Recombinant Adenovirus-associated Virus

Advanced biomanufacturing and evaluation of adeno-associated virus

Preparation of the human brain-derived neurotrophic factor recombinant adeno-associated virus

Construction of Recombinant Adenovirus for the Angiogenic Inhibitor,Vasostatin,and Its Expression in Vitro

Construction of Recombinant Adeno-Associated Virus Vector with Human Preproenkephalin Gene

Construction of Recombinant Adeno-Associated Virus Vector Co-Expressing Hvegf165 and Hbmp7 Gene

Construction of vector of recombinant adeno-associated virus including NT4-GFP-Ant fusional reporting gene and significance